COFFMAN ROBERT 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Mar 1, 2019
Insider Transaction Report
Form 4
COFFMAN ROBERT
Chief Scientific Officer & VP
Transactions
- Sale
Common Stock
2019-02-28$9.03/sh−8,500$76,755→ 77,768 total - Sale
Common Stock
2019-02-28$9.03/sh−54,702$493,959→ 86,268 total